Brief: Vallon Pharmaceuticals Reports Third Quarter 2022 Results
03/11/2022 21:22
Nov 3 (Reuters) - Vallon Pharmaceuticals Inc VLON.O :
* VALLON PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS
* VALLON PHARMACEUTICALS INC - QTRLY NET LOSS $1.0 MILLION
Source text for Eikon: ID:nGNXb5wc2m
Further company coverage: VLON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GRI Bio
See all newsGRI Bio Inc reports results for the quarter ended June 30 - Earnings Summary
GRI Bio Inc expected to post a loss of $1.19 a share - Earnings Preview
Brief: Gri Bio Secures FDA Orphan Drug Designation For Gri-0621 (Tazarotene) In Idiopathic Pulmonary Fibrosis
GRI Bio Q1 net loss narrows on lower R&D expenses
GRI Bio raises $14.5 mln to fund operations into Q1 2027